| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.047 | 29.653 | 8.872 | 18.406 | 19.783 | 35.997 | 50.673 | 65.240 | 104.334 | 55.155 |
| Total Income - EUR | 16.047 | 29.653 | 8.872 | 18.410 | 19.783 | 35.997 | 50.673 | 65.240 | 104.417 | 57.275 |
| Total Expenses - EUR | 17.883 | 30.349 | 5.899 | 18.196 | 17.060 | 24.902 | 48.031 | 53.805 | 74.101 | 46.212 |
| Gross Profit/Loss - EUR | -1.836 | -696 | 2.973 | 214 | 2.722 | 11.095 | 2.643 | 11.435 | 30.316 | 11.063 |
| Net Profit/Loss - EUR | -2.317 | -1.289 | 2.707 | 30 | 2.225 | 10.763 | 2.197 | 10.795 | 29.293 | 10.576 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bioprest Complet Business Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 323 | 347 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.719 |
| Current Assets | 1.242 | 2.456 | 571 | 1.448 | 2.877 | 13.754 | 16.324 | 13.470 | 40.155 | 25.330 |
| Inventories | 1.029 | 79 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 109 | 947 | 683 | 3.721 | 8.503 | 31.151 | 17.514 |
| Cash | 214 | 2.377 | 571 | 1.339 | 1.929 | 13.070 | 12.603 | 4.967 | 9.004 | 7.816 |
| Shareholders Funds | -2.272 | -3.538 | -772 | -728 | 1.511 | 12.245 | 14.170 | 10.844 | 29.341 | 35.383 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.837 | 6.342 | 1.407 | 2.176 | 1.366 | 1.509 | 2.237 | 3.198 | 11.314 | 4.318 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4721 - 4721" | |||||||||
| CAEN Financial Year |
4721
|
|||||||||
Comments - Bioprest Complet Business Srl